Dermata Therapeutics Inc.

DRMA | NASDAQ

Price Alert Chart Builder DCF Calculator

$1.15

$0 (0.00%)

At close: Sep 22, 2026, 4:00 PM ET

$1.22

+$0.07 (+6.09%)

After-hours: Sep 22, 2026, 7:42 PM ET

Overview Rating Statistics Financials Earnings Analysts Ownership Profile

Overview Market Cap Employees

Company Profile

Dermata Therapeutics, Inc. engages in the development and distribution of over-the-counter pharmaceutical dermatology-focused products in the United States. The company develops direct-to-consumer skincare products, including foundation treatment products for skin renewal and clearing treatment products for the treatment of acne under the Tome brand. Dermata Therapeutics, Inc. was incorporated in 2014 and is headquartered in San Diego, California.

Key Executives

Name	Position
Gerald T. Proehl	Founder, President, Chief Executive Officer & Chairman
Kyri K. Van Hoose	Senior Vice President & Chief Financial Officer
Christopher J. Nardo	Senior Vice President & Chief Development Officer
David F. Hale	Co-Founder & Lead Independent Director
Kyra Peckaitis	Vice President of Marketing
Maria Bedoya Toro Munera	Senior Vice President of Regulatory Affairs & Quality Assurance
Sean Proehl	Associate General Counsel

Latest SEC Filings

Date	Type	Title
Aug 18, 2026	4	Filing
Aug 18, 2026	4	Filing
Aug 17, 2026	25-NSE	Filing
Aug 17, 2026	8-K	Current Report
Aug 11, 2026	10-Q	Quarterly Report
Aug 11, 2026	8-K	Current Report
Aug 05, 2026	8-K	Current Report
Jun 16, 2026	4	Filing
Jun 04, 2026	S-8	Filing
Jun 01, 2026	SC 13D	Filing

View All SEC Filings ➞

Dermata Therapeutics Inc.

Country	United States
IPO Date	Aug 12, 2021
Industry	Biotechnology
Sector	Healthcare
Employees	9
CEO	Gerald T. Proehl

Contact Details

3525 Del Mar Heights Road San Diego, California 92130 United States

https://www.dermatarx.com

858 800 2543

Stock Details

Ticker Symbol	DRMA
Exchange	NASDAQ
Fiscal Year	January - December
Reporting Currency	USD
CIK Code	0001853816
CUSIP Number	249845504
ISIN Number	US2498455045
SIC Code	2834